Member Company


Reulay’s mission is to increase the quality of life and longevity for 2 billion humans by creating effective, scalable, and affordable digital health therapeutics. 

Reulay’s virtual therapeutic platform leverages biometrics, digital behavior, brain science, epigenetics research, and machine learning to personalize evidence-based digital medicine that targets human biology for prevention and treatment.

Reulay is advancing a broad pipeline of patented products across VR, AR, Mobile, & Web interventions to decrease stress and anxiety disorders, as well as associated chronic medical conditions such as cancer, stroke, heart disease & neurodegenerative diseases.


Copyright © 2024 Digital Therapeutics Alliance™